1. Cabanillas F (1989). Experience with ifosfamide combinations in malignant lymphomas. Semin Oncol 16(1, Suppl 3):78–81.
2. Non-Hodgkin’s Lymphoma Pathologic Classification Project (1982). National Cancer Institute sponsored study of classification of non-Hodgkin’s lymphomas: summary and description of a Working Formulation for clinical usage. Cancer 49:2112–2135.
3. Cavalli F, Jungi WF, Sonntag W, et al. (1980). Phase-II studie Mit Cis-Diammine-dichloroplatinum (II) in der behand lung fortgeschrittener maligner lymphome. Schweiz Med Woschenschr 110:1067–1072.
4. Kantarjian H, Barlogie B, Plunkett W, et al. (1983). High dose cytosine arabinoside in non-Hodgkin’s lymphoma. J Clin Oncol 1:689–694.
5. Bergerat JP, Drewinko B, Corry P, et al. (1981). Synergistic lethal effect of cis-dicholorodiammine platinum and 1-b-D-arabinosylcytosine. Cancer Res 41:25–31.